Here are four points:
1. The Senate Committee on Health, Education, Labor, and Pensions voted to move Dr. Gottlieb’s confirmation to its final stage in a 14- to-nine vote.
2. Next steps entail the Senate floor voting on Dr. Gottlieb’s nomination.
3. Some Democratic officials have voiced concern about the pick, saying Dr. Gottlieb has conflicts of interest due to his past healthcare and pharmaceutical ties. STAT reports Dr. Gottlieb has recused himself from agency work during his past experience as FDA commissioner and has vowed to do so again if these relationships pose issues.
4. Five senators request that Dr. Gottlieb answer more questions about how he would combat FDA funding and staffing issues before the final Senate vote.
More articles on leadership and management:
American Nurses Credentialing Center recognizes Bethesda Surgery Center for nursing excellence: 3 takeaways
4 key points on Tenet’s CNO Dian Adams
TeamHealth names medical directors, advanced practice clinician of the year
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
